GuangYuYuan Chinese Herbal Medicine Co., Ltd. (SHA:600771)
China · Delayed Price · Currency is CNY 20.12
+0.44 (2.24%)
Sep 5, 2025, 3:00 PM CST
SHA:600771 Revenue
GuangYuYuan Chinese Herbal Medicine had revenue of 362.14M CNY in the quarter ending June 30, 2025, with 14.52% growth. This brings the company's revenue in the last twelve months to 1.34B, up 7.28% year-over-year. In the year 2024, GuangYuYuan Chinese Herbal Medicine had annual revenue of 1.22B, down -4.87%.
Revenue (ttm)
1.34B
Revenue Growth
+7.28%
P/S Ratio
7.34
Revenue / Employee
772.97K
Employees
1,735
Market Cap
9.85B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.22B | -62.59M | -4.87% |
| Dec 31, 2023 | 1.28B | 153.30M | 13.56% |
| Dec 31, 2022 | 1.13B | 276.50M | 32.37% |
| Dec 31, 2021 | 854.22M | -255.21M | -23.00% |
| Dec 31, 2020 | 1.11B | -107.67M | -8.85% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 30.15B |
| WuXi AppTec | 41.90B |
| Shenzhen Mindray Bio-Medical Electronics | 32.94B |
| Sichuan Biokin Pharmaceutical | 441.19M |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.52B |
| Aier Eye Hospital Group | 21.94B |
| Shanghai United Imaging Healthcare | 10.98B |
| Yunnan Baiyao Group Co.,Ltd | 40.84B |